These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1980769)

  • 21. The use of octreotide to treat congenital chylothorax.
    Paget-Brown A; Kattwinkel J; Rodgers BM; Michalsky MP
    J Pediatr Surg; 2006 Apr; 41(4):845-7. PubMed ID: 16567206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful treatment with octreotide of spontaneous chylothorax in a premature infant.
    Coulter DM
    J Perinatol; 2004 Mar; 24(3):194-5. PubMed ID: 15044931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis in an infant treated with octreotide for congenital hyperinsulinism.
    Koren I; Riskin A; Barthlen W; Gillis D
    J Pediatr Endocrinol Metab; 2013; 26(1-2):183-5. PubMed ID: 23327817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Octreotide in the treatment of the dumping syndrome.
    Primrose JN
    Digestion; 1990; 45 Suppl 1():49-58; discussion 58-9. PubMed ID: 2335268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Octreotide therapy in AIDS-related, refractory diarrhea: results of a multicentre Canadian-European study. Octreotide International Multicentre AIDS-Diarrhea Study.
    Montaner JS; Harris AG
    AIDS; 1995 Feb; 9(2):209-10. PubMed ID: 7718196
    [No Abstract]   [Full Text] [Related]  

  • 26. Marked improvement of diabetic diarrhea with the somatostatin analogue octreotide.
    Nakabayashi H; Fujii S; Miwa U; Seta T; Takeda R
    Arch Intern Med; 1994 Aug; 154(16):1863-7. PubMed ID: 8053756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary intestinal lymphangiectasia in children: is octreotide an effective and safe option in the treatment?
    Sari S; Baris Z; Dalgic B
    J Pediatr Gastroenterol Nutr; 2010 Oct; 51(4):454-7. PubMed ID: 20512058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comments on "Clinical value of monitoring plasma octreotide levels during chronic octreotide long-acting repeatable therapy in carcinoid patients".
    Schran HF; Hager DF
    Pancreas; 2008 Oct; 37(3):334-5; author reply 336-7. PubMed ID: 18815560
    [No Abstract]   [Full Text] [Related]  

  • 29. [Therapeutic applications of somatostatin and its analog, octreotide].
    Harris AG; Kokoris SP
    Presse Med; 1993 Apr; 22(15):724-33. PubMed ID: 8099737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of octreotide in the treatment of mesenteric angina.
    Anderson SH; Dalton HR
    Am J Gastroenterol; 1997 Jul; 92(7):1222-3. PubMed ID: 9219806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conservative management of pediatric pancreatic pseudocyst using octreotide acetate.
    Mulligan C; Howell C; Hatley R; Martindale R; Clark J
    Am Surg; 1995 Mar; 61(3):206-9. PubMed ID: 7887530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical use of somatostatin analogues (Sandostatin, SMS 20l-995). Proceedings of a symposium. Amsterdam, November 14, 1986.
    Acta Endocrinol Suppl (Copenh); 1987; 286():1-66. PubMed ID: 2892333
    [No Abstract]   [Full Text] [Related]  

  • 33. Octreotide-induced hepatitis in a child with persistent hyperinsulinemia hypoglycemia of infancy.
    Ben-Ari J; Greenberg M; Nemet D; Edelstein E; Eliakim A
    J Pediatr Endocrinol Metab; 2013; 26(1-2):179-82. PubMed ID: 23327813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Upper digestive hemorrhage. Comparison of terlipressin and octreotide].
    Campisi C; Padula P; Peressini A; Boccardo F; Biraghi M; Casaccia M
    Minerva Chir; 1993 Oct; 48(19):1091-6. PubMed ID: 8309607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of acromegaly with octreotide, a synthetic analog of somatostatin with extended action].
    Arosio M; Bazzoni N; Faglia G
    Minerva Endocrinol; 1990; 15(1):29-36. PubMed ID: 2274011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of the somatostatin analog octreotide in the treatment of two patients with refractory diabetic diarrhea.
    Walker JJ; Kaplan DS
    Am J Gastroenterol; 1993 May; 88(5):765-7. PubMed ID: 8480746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of octreotide to successfully treat protein-losing enteropathy following the Fontan operation.
    John AS; Phillips SD; Driscoll DJ; Warnes CA; Cetta F
    Congenit Heart Dis; 2011; 6(6):653-6. PubMed ID: 21545466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Octreotide therapy for chylous ascites in a chronic dialysis patient.
    Lee PH; Lin CL; Lai PC; Yang CW
    Nephrology (Carlton); 2005 Aug; 10(4):344-7. PubMed ID: 16109079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histopathological study on the effect of octreotide.
    Yokoyama S; Goto M; Asakura T; Hirahara K; Tsuyama S; Murata F
    Noshuyo Byori; 1995 Mar; 12(1):7-13. PubMed ID: 7795733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Octreotide--a somatostatin analog in clinical practice].
    Meier R
    Praxis (Bern 1994); 1995 Mar; 84(12):325-7. PubMed ID: 7701170
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.